Your browser doesn't support javascript.
loading
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C C; Fuhlbrigge, R C; Casasnovas, J M; Aiuti, A; Springer, T A.
Afiliação
  • Bleul CC; The Center for Blood Research, Harvard Medical School, Department of Pathology, Boston, Massachusetts 02115, USA.
J Exp Med ; 184(3): 1101-9, 1996 Sep 01.
Article em En | MEDLINE | ID: mdl-9064327
ABSTRACT
Chemotactic factors are postulated to direct emigration of lymphocytes from the blood stream into sites of inflammation. Members of a family of chemotactic cytokines, termed chemokines, have been shown to attract lymphocytes but efficacy, i.e., the maximal percentage of attracted cells, has been low. We have identified a highly efficacious lymphocyte chemotactic activity in the supernatants of the murine bone marrow stroma cell line MS-5 which attracts 10-fold more lymphocytes in vitro than currently described lymphocyte chemoattractants. Purification of this chemotactic activity revealed identity to stromal cell-derived factor 1 (SDF-1). SDF-1 acts on lymphocytes and monocytes but not neutrophils in vitro and is both a highly efficacious and highly potent mononuclear cell attractant in vivo. In addition, SDF-1 induces intracellular actin polymerization in lymphocytes, a process that is thought to be a prerequisite for cell motility. Since SDF-1 is expressed constitutively in a broad range of tissues it may have a role in immune surveillance and in basal extravasation of lymphocytes and monocytes rather than in inflammation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimiocinas / Quimiocinas CXC Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 1996 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimiocinas / Quimiocinas CXC Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 1996 Tipo de documento: Article